Role of Positron Emission Tomography in Lymphoma-Reference-Cited by-同舟云学术

Role of Positron Emission Tomography in Lymphoma

Published:2005-07-20 Issue:21 Volume:23 Page:4577-4580
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Juweid Malik E.¹,Cheson Bruce D.²

Affiliation:

1. Department of Radiology and Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA

2. Department of Internal Medicine, Georgetown University Hospital, Washington, DC

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.01.904

Reference24 articles.

1. Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma

2. Rodriguez M, Rehn S, Ahlstrom H, et al: Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J Nucl Med 36:1790,1995-1796,

3. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18- fluorodeoxyglucose

4. Leskinen-Kallio S, Ruotsalainen U, Nagren K, et al: Uptake of C-11 methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study. J Nucl Med 32:1211,1991-1218,

5. Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial;International Journal of Hematology;2024-03-22

2. Значение ПЭТ, совмещенной с КТ, при диффузной В-крупноклеточной лимфоме: история вопроса, эволюция представлений и современные возможности метода (обзор литературы);Clinical Oncohematology;2024-02-20

3. PET/CT in Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05

4. Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma;Scientific Reports;2022-10-21

5. Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update;Cancer;2021-07-19